Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: A transformed event

Leukemia Research

Volumn 22, Issue 9, 1998, Pages 817-826

  Hu, Xiaotang ^a   Moscinski, Lynn C ^b   Hill, Bobbye J ^b   Chen, Quanlu ^b   Wu, Jie ^b   Fisher, Ariana Brown ^a   Zuckerman, Kenneth S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

CD34; CD38; Cell line; MAP kinase; Transformation; Tumorigenicity

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL TRANSFORMATION; HUMAN; HUMAN CELL; NUDE MOUSE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; HUMANS; INTERLEUKINS; LEUKEMIA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032171605     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00073-3     Document Type: Article

References (31)

1. [1] Stocking C, Loliger C, Kawai M, Suciu S, Gough N, Ostertag W. Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor independent mutants. Cell 1988;53:869.
2. [2] Schuler GD, Cole MD. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 1988;55:1115.
3. [3] Duhrsen U, Stahi J, Gough NM. In vivo transformation of factor-dependent hemopoietic cells: Role of intracisternal A-particle transposition for growth factor gene activation. EMBO J 1990;9:1087.
4. [4] Russell NH. Autocrine growth factors and leukaemic haemopoiesis. Blood Rev 1992;6:149.
5. [5] Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 1996;88:809.
6. [6] Meckling GK, Yes SP, Schrader JW, Pawson T. A retrovirus encoding the v-fps protein-tyrosine kinase induces factor-independent growth and tumorigenicity in FDC-P 1 cells. Biochim Biophys Acta 1992;1137:65.
7. [7] Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975;45:321.
8. [8] Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976;17:565.
9. [9] Koeffler HP, Golde DW. Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity. Science 1978;200:1153.
10. [10] Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 1980;56:265.
11. [11] Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980;26:171.
12. [12] Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I, Griffin C, Emanuel B, Finan J, Nowell P, Rovera G. Growth factor requirements of childhood acute leukemia: Establishment of GM-CSF-dependent cell lines. Blood 1987;70:192.
13. [13] Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989;140:323.
14. [14] Gabert KA, Lopez M, Bangs CD, Martina N, Donlon TA, Mannoni P, Lee F. Characterization of spontaneous factor-independent cell lines derived from human leukemic cell line TF-1: A dominant event. Leukemia 1994;8:1359.
15. [15] Kizaki M, Matsushita H, Takayama N, Muto A, Ueno H, Awaya N, Kawai Y, Asou H, Kamada N, Ikeda Y. Establishment and characterization of a novel acute promyelocytic leukemia cell line (IJF-1) with retinoic acid-resistant features. Blood 1996;88:1824.
16. [16] Buick R, Minden M, McCulloch E. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood 1970;54:95.
17. [17] Keller JR, McNiece IK, Sill KT, Ellingsworth LR, Quesenberry PJ, Sing GK, Ruscetti FW. Transforming growth factor-β1 directly regulates primitive murine hematopoietic cell proliferation. Blood 1990;75:596.
18. [18] Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH. Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood 1996;88:82.
19. [19] McNiece IK, Bertoncello I, Keller JR, Ruscetti FW, Hartley CA, Zsebo KM. Transforming growth factor β inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int J Cell Cloning 1992;10:80.
20. [20] Shipley GD, Pittelkow MR, Willie JJ Jr, Scott RE, Moses HL. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 1986;46:2068.
21. [21] Knabble C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987;48:417.
22. [22] Masui T, Wakefield LM, Lechner JF, LaVeck MA, Sporn MB, Harris CC. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 1986;83:2438.
23. [23] Alexandrow MG, Moses HL. Transforming growth factor β and cell cycle regulation. Cancer Res 1995;55:1452.
24. [24] Manning AM, Williams AC, Game SM, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 1991;6:1471.
25. - progenitor cells. Blood 1991;77:1218.
26. - hematopoietic stem cells. Blood 1994;83:1515.
27. + hemopoietic cells from human bone marrow. J Exp Med 1990;172:363.
28. [28] Brandt J, Srour EF, Van Besien K, Bridell RA, Hoffman R. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest 1990;86:932.
29. [29] Verfaillie CM, Blakholmer K, McGlave PB. Purified primitive human hematopoietic progenitors with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 1990;172:509.
30. [30] Snoeck HS, Weekx S, Moulijn A, Lardon F, Lenjou M, Nys G, Van Ranst PCF, Van Bockstaele DR, Berneman ZN. Tumor necrosis factor α is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor β but not to interferon γ. J Exp Med 1996;183:705.
31. - cord blood stem cells into B-cell progenitors in vitro. Exp Hematol 1997;25:66.